Methods and materials for increasing potency of cells

US9506031B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9506031-B2
Application numberUS-201414563459-A
CountryUS
Kind codeB2
Filing dateDec 8, 2014
Priority dateOct 22, 2004
Publication dateNov 29, 2016
Grant dateNov 29, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Disclosed herein are methods and materials for producing a more developmentally potent cell from a less developmentally potent cell. Specifically exemplified herein are methods that comprise introducing an expressible dedifferentiating polynucleotide sequence into a less developmentally potent cell, wherein the transfected less developmentally potent cell becomes a more developmentally potent cell capable of differentiating to a less developmentally potent cell of its lineage of origin or a different lineage.

First claim

Opening claim text (preview).

What is claimed is: 1. A mesenchymal stem cell possessing increased developmental potency, said mesenchymal stem cell produced by introducing into said mesenchymal stem cell at least one polynucleotide comprising coding regions for oct4 and sox2, wherein expression of said coding regions causes an increase of nanog in the mesenchymal stem cell, and wherein said expression results in higher developmental potency of said mesenchymal stem cell. 2. A cell produced by a method comprising introducing into a mesenchymal cell at least one polynucleotide encoding oct4 and at least one polynucleotide encoding sox2.

Assignees

Inventors

Classifications

  • for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia · CPC title

  • Nanog · CPC title

  • from mesenchymal stem cells · CPC title

  • Genetically modified cells · CPC title

  • Bone marrow mesenchymal stem cells (BM-MSC) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9506031B2 cover?
Disclosed herein are methods and materials for producing a more developmentally potent cell from a less developmentally potent cell. Specifically exemplified herein are methods that comprise introducing an expressible dedifferentiating polynucleotide sequence into a less developmentally potent cell, wherein the transfected less developmentally potent cell becomes a more developmentally potent c…
Who is the assignee on this patent?
Sugaya Kiminobu, Alvarez Angel, Univ Central Florida Res Found Inc
What technology area does this patent fall under?
Primary CPC classification C12N5/0657. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Nov 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).